Further demonstration of the diversity of chromosomal changes involving 2p23 in ALK-positive lymphoma: 2 cases expressing ALK kinase fused to CLTCL (clathrin chain polypeptide-like)

Blood

Volumn 95, Issue 10, 2000, Pages 3204-3207

  Touriol, Christian ^b   Greenland, Catherine ^b   Lamant, Laurence ^b   Pulford, Karen ^b   Bernard, Frédéric ^b   Rousset, Thérèse ^b   Mason, David Y ^b   Delsol, Georges ^a  

^a CHU PURPAN   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CLATHRIN; HYBRID PROTEIN; NUCLEOPHOSMIN;

ADULT; ARTICLE; AUTOPHOSPHORYLATION; CASE REPORT; CHROMOSOME 2P; CHROMOSOME TRANSLOCATION; DNA SEQUENCE; ENZYME MECHANISM; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPHOMA; MALE; MALIGNANT TRANSFORMATION; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION;

EID: 0034658434     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v95.10.3204.010k04_3204_3207     Document Type: Article

References (34)

1. Benharroch D, Meguerian-Bedoyan Z, Lamant L, et al. ALK-positive lymphoma: a single disease with a broad spectrum of morphology. Blood. 1998; 91:2076-2084.
2. Falini B, Bigerna B, Fizzotti M, et al. ALK expression defines a distinct group of T/null lymphomas ("ALK lymphomas") with a wide morphological spectrum. Am J Pathol. 1998;153:875-886.
3. Bitter M, Franklin W, Larson R, et al. Morphology in Ki-1 (CD30)-positive non-Hodgkin's lymphoma is correlated with clinical features and the presence of a unique chromosomal abnormality, t(2; 5)(p23;q35). Am J Surg Pathol. 1990;14:305-316.
4. Lamant L, Meggetto F, al Saati T, et al. High incidence of the t(2;5)(p23;q35) translocation in anaplastic large cell lymphoma and its lack of detection in Hodgkin's disease. Comparison of cytogenetic analysis, reverse transcriptase-polymerase chain reaction, and P-80 immunostaining. Blood. 1996;87:284-291.
5. Mason DY, Bastard C, Rimokh R, et al. CD30-positive large cell lymphomas (Ki-1 lymphoma) are associated with a chromosomal translocation involving 5q35 [see comments]. Br J Haematol. 1990;74:161-168.
6. Wellmann A, Otsuki T, Vogelbruch M, et al. Analysis of the t(2;5)(p23;q35) translocation by reverse transcription-polymerase chain reaction in CD30+ anaplastic large-cell lymphomas, in other non-Hodgkin's lymphomas of T-cell phenotype, and in Hodgkin's disease. Blood. 1995;86:2321-2328.
7. Morris SW, Kirstein MN, Valentine MB, et al. Fusion of a kinase gene. ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma [published erratum appears in Science 1995 Jan 20: 267(5196):316-7]. Science. 1994;263:1281-1284.
8. Chan J. Anaplastic large cell lymphoma: redefining its morphologic spectrum and importance of recognition of the ALK-positive subset. Adv Anat Pathol. 1998;5:281-313.
9. Chan PK, Chan FY, Morris SW, Xie Z. Isolation and characterization of the human nucleophosmin/B23 (NPM) gene: identification of the YY1 binding site at the 5′ enhancer region. Nucleic Acids Res. 1997;25:1225-1232.
10. Bischof D, Pulford K, Mason DY, Morris SW. Role of the nucleophosmin (NPM) portion of the non-Hodgkin's lymphoma-associated NPM-anaplastic lymphoma kinase fusion protein in oncogenesis. Mol Cell Biol. 1997;17:2312-2325.
11. Mason DY, Pulford KA, Bischof D, et al. Nucleolar localization of the nucleophosmin-anaplastic lymphoma kinase is not required for malignant transformation. Cancer Res. 1998;58:1057-1062.
12. Wlodarska I, De Wolf-Peeters C, Falini B, et al. The cryptic inv(2)(p23q35) defines a new molecular genetic subtype of ALK-positive anaplastic large-cell lymphoma. Blood. 1998;92:2688-2695.
13. Pittaluga S, Wiodarska I, Pulford K, et al. The monoclonal antibody ALK1 identifies a distinct morphological subtype of anaplastic large cell lymphoma associated with 2p23/ALK rearrangements. Am J Pathol. 1997;151:343-351.
14. Lamant L, Dastugue N, Pulford K, Delsol G, Mariame B. A new fusion gene TPM3-ALK in anaplastic large cell lymphoma created by a (1;2)(q25; p23) translocation. Blood. 1999;93:3088-3095.
15. Pulford K, Falini B, Cordell J, et al. Biochemical detection of novel anaplastic lymphoma kinase proteins in tissue sections of anaplastic large cell lymphoma. Am J Pathol. 1999;154:1657-1663.
16. Rosenwald A, Ott G, Pulford K, et al. t(1;2)(q21; p23) and t(2;3)(p23;q21): two novel variant translocations of the t(2;5)(p23;q35) in anaplastic large cell lymphoma. Blood. 1999;94:362-366.
17. Hernandez L, Pinyol M, Hernandez S, et al. TRK-fused gene (TFG) is a new partner of ALK in anaplastic large cell lymphoma producing two structurally different TFG-ALK translocations. Blood. 1999;94:3265-3268.
18. Pulford K, Lamant L, Morris SW, et al. Detection of anaplastic lymphoma kinase (ALK) and nucleolar protein nucleophosmin (NPM)-ALK proteins in normal and neoplastic cells with the monoclonal antibody ALK1. Blood. 1997;89:1394-1404.
19. Kedra D, Peyrard M, Fransson I, et al. Characterization of a second human clathrin heavy chain polypeptide gene (CLH-22) from chromosome 22q11. Hum Mol Genet. 1996;5:625-631.
20. Long KR, Trofatter JA, Ramesh V, McCormick MK, Buckler AJ. Cloning and characterization of a novel human clathrin heavy chain gene (CLTCL). Genomics. 1996;35:466-472.
21. Dodge GR, Kovalszky I, McBride OW, et al. Human clathrin heavy chain (CLTC): partial molecular cloning, expression, and mapping of the gene to human chromosome 17q11-qter. Genomics. 1991;11:174-178.
22. Park JP, Curran MJ, Levy NB, et al. Diffuse large cell, B-cell type lymphoma with a novel translocation (2;22)(p23;q11.2). Cancer Genet Cytogenet. 1997;96:118-122.
23. Holmes SE, Riazi MA, Gong W, et al. Disruption of the clathrin heavy chain-like gene (CLTCL) associated with features of DGS/VCFS: a balanced (21;22)(p12;q11) translocation. Hum Mol Genet. 1997;6:357-367.
24. Kirchhausen T, Harrison SC, Chow EP, et al. Clathrin heavy chain: molecular cloning and complete primary structure. Proc Natl Acad Sci U S A. 1987;84:8805-8809.
25. Schmid SL. Clathrin-coated vesicle formation and protein sorting: an integrated process. Annu Rev Biochem. 1997;66:511-548.
26. Morris S, Ahle S, Ungewickell E. Clathrin-coated vesicles. Curr Opin Cell Biol. 1989;1:684-690.
27. Pearse B. Clathrin and coated vesicles. Embo J. 1987;6:2507-2512.
28. Pishvaee B, Payne GS. Clathrin coats - threads laid bare. Cell. 1998;95:443-446.
29. Nathke IS, Heuser J, Lupas A, et al. Folding and trimerization of clathrin subunits at the triskelion hub. Cell. 1992;68:899-910.
30. Ybe J, Brodsky F, Hofmann K, et al. Clathrin self-assembly is mediated by a tandemly repeated superhelix. Nature. 1999;399:371-375.
31. Delsol G, Lamant L, Benharroch D, et al. Systemic anaplastic large cell lymphomas: diagnostic criteria and significance of morphology, ALK-expression, 2;5 translocation and age. World Health Organization Clinical Advisory Committee Meeting: Classification of Neoplastic Disease of the Hematopoietic and Lymphoid System. Airlie, VA, November 3-5, 1997.
32. Gascoyne R, Aoun P, Wu D, et al. Prognostic significance of anaplastic lymphoma kinase (ALK) protein expression in adults with anaplastic large cell lymphoma. Blood. 1999;93:3913-3921.
33. Falini B, Pileri S, Zinzani P, et al. ALK+ lymphoma: clinico-pathological findings and outcome. Blood. 1999;93:2697-2706.
34. Falini B, Pulford K, Pucciarini A, et al. Lymphomas expressing ALK fusion Protein other than NPM-ALK. Blood. 1999;94:3509-3515.